
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT
- About


Teladoc Inc (TDOC)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/10/2025: TDOC (1-star) has a low Upturn Star Rating. Not recommended to BUY.
1 Year Target Price $9.18
1 Year Target Price $9.18
3 | Strong Buy |
2 | Buy |
19 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -22.01% | Avg. Invested days 31 | Today’s Advisory WEAK BUY |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.41B USD | Price to earnings Ratio - | 1Y Target Price 9.18 |
Price to earnings Ratio - | 1Y Target Price 9.18 | ||
Volume (30-day avg) 24 | Beta 1.91 | 52 Weeks Range 6.35 - 15.21 | Updated Date 10/12/2025 |
52 Weeks Range 6.35 - 15.21 | Updated Date 10/12/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.15 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -8.16% | Operating Margin (TTM) -7.29% |
Management Effectiveness
Return on Assets (TTM) -3.57% | Return on Equity (TTM) -14.18% |
Valuation
Trailing PE - | Forward PE 357.14 | Enterprise Value 1853807813 | Price to Sales(TTM) 0.56 |
Enterprise Value 1853807813 | Price to Sales(TTM) 0.56 | ||
Enterprise Value to Revenue 0.73 | Enterprise Value to EBITDA 11.66 | Shares Outstanding 176690662 | Shares Floating 174736463 |
Shares Outstanding 176690662 | Shares Floating 174736463 | ||
Percent Insiders 0.99 | Percent Institutions 74.47 |
Upturn AI SWOT
Teladoc Inc

Company Overview
History and Background
Teladoc Inc. was founded in 2002 and is headquartered in Purchase, New York. It provides telehealth services globally. Initially focused on telephone-based consultations, it expanded to video and other digital platforms, growing through acquisitions and organic expansion.
Core Business Areas
- Teladoc Health Integrated Care: Provides a comprehensive suite of virtual care services, including primary care, mental health, and specialty care, delivered through a unified platform.
- BetterHelp: Offers direct-to-consumer mental health services, connecting users with licensed therapists via online messaging, video, and phone sessions.
- Access Solutions: Provides expert medical services (EMS) and programs, including expert medical opinion, navigation and care coordination, and health data analytics.
Leadership and Structure
Jason Gorevic serves as the Chief Executive Officer. The company operates with a hierarchical structure, with distinct divisions for integrated care, BetterHelp, and Access Solutions, each managed by dedicated leadership teams. A board of directors oversees corporate governance.
Top Products and Market Share
Key Offerings
- Teladoc Primary360: Virtual primary care service offering routine check-ups, chronic condition management, and urgent care. Market share is challenging to precisely quantify due to the fragmented nature of the telehealth market. Competitors include Amwell, Doctor on Demand, and MDLive. Revenue from primary care is integrated within the Teladoc Health Integrated Care segment and is not reported separately. The number of users is also proprietary information.
- BetterHelp: Direct-to-consumer mental health service connecting users with therapists. BetterHelp is a significant player in the online therapy market. Competitors include Talkspace and Cerebral. Revenue is reported as part of the BetterHelp segment. User numbers are proprietary.
- Teladoc Medical Experts: Provides expert medical opinions from specialists. Competitors include Grand Rounds Health and 2nd.MD. Revenue data is not separately disclosed.
Market Dynamics
Industry Overview
The telehealth industry is experiencing significant growth driven by increasing demand for convenient and accessible healthcare, technological advancements, and regulatory changes. It is competitive and evolving rapidly.
Positioning
Teladoc is a leading player in the telehealth market, offering a wide range of services and a large user base. Its competitive advantages include its established brand, broad service portfolio, and technology platform. However, it faces intense competition from other telehealth providers and traditional healthcare systems.
Total Addressable Market (TAM)
The global telehealth market is projected to reach hundreds of billions of dollars in the coming years. Teladoc is well-positioned to capture a significant share of this market due to its comprehensive service offerings and established presence. However, competition and the evolving regulatory landscape pose challenges.
Upturn SWOT Analysis
Strengths
- Established brand recognition
- Wide range of telehealth services
- Large user base
- Technology platform
- Extensive network of physicians
Weaknesses
- Profitability concerns
- High marketing expenses
- Integration challenges after acquisitions
- Reliance on acquisitions for growth
- Fluctuations in demand based on seasonal illness and other factors
Opportunities
- Expanding telehealth adoption
- Increasing demand for mental health services
- Partnerships with healthcare providers and payers
- Technological advancements in telehealth
- Growing global market for telehealth
Threats
- Intense competition
- Changing regulations
- Reimbursement pressures
- Data security and privacy concerns
- Economic downturn impacting consumer spending
Competitors and Market Share
Key Competitors
- AMWL
- LVGO
- CERE
Competitive Landscape
Teladoc has a broad range of services, but Amwell (AMWL) poses a strong challenge. Other competitors focus on niche areas, leading to a diverse market. Teladoc's scale is an advantage, but profitability and innovation are crucial to maintain its position. LVGO (Livongo) was acquired by Teladoc, though some aspects of it may operate independently within Teladoc's structure.
Major Acquisitions
Livongo
- Year: 2020
- Acquisition Price (USD millions): 18500
- Strategic Rationale: Expanded Teladoc's chronic care management capabilities and broadened its reach to individuals with diabetes and hypertension.
Growth Trajectory and Initiatives
Historical Growth: Teladoc has experienced significant revenue growth in recent years, driven by increased telehealth adoption and acquisitions. However, profitability has been a challenge.
Future Projections: Analyst estimates suggest continued revenue growth for Teladoc, but profitability remains uncertain. The company's success will depend on its ability to control costs, integrate acquisitions, and innovate its service offerings.
Recent Initiatives: Teladoc is focusing on expanding its integrated care services, improving the user experience on its platform, and partnering with healthcare providers and payers.
Summary
Teladoc is a leading telehealth company with an extensive service offering and established brand. While it has achieved significant revenue growth, profitability remains a concern. Teladoc needs to focus on integrating acquisitions, controlling costs, and innovating to maintain its competitive advantage. It should monitor competitors and adapt to the evolving regulatory environment.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Industry reports
- Analyst estimates
Disclaimers:
The data and analysis provided are for informational purposes only and should not be considered investment advice. Market share data is approximate. Financial data is subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Teladoc Inc
Exchange NYSE | Headquaters Purchase, NY, United States | ||
IPO Launch date 2015-07-01 | CEO & Director Mr. Charles Divita III, CPA | ||
Sector Healthcare | Industry Health Information Services | Full time employees 4620 | Website https://www.teladochealth.com |
Full time employees 4620 | Website https://www.teladochealth.com |
Teladoc Health, Inc. provides virtual healthcare services worldwide. It operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counselling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.